362 related articles for article (PubMed ID: 24452673)
1. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
2. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.
Curran D; Giralt J; Harari PM; Ang KK; Cohen RB; Kies MS; Jassem J; Baselga J; Rowinsky EK; Amellal N; Comte S; Bonner JA
J Clin Oncol; 2007 Jun; 25(16):2191-7. PubMed ID: 17538164
[TBL] [Abstract][Full Text] [Related]
5. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
[TBL] [Abstract][Full Text] [Related]
6. Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial.
Driessen CML; Groenewoud JMM; de Boer JP; Gelderblom H; van der Graaf WTA; Prins JB; Kaanders JHAM; van Herpen CML
Support Care Cancer; 2018 Apr; 26(4):1233-1242. PubMed ID: 29230548
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
8. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.
Singer S; Araújo C; Arraras JI; Baumann I; Boehm A; Brokstad Herlofson B; Castro Silva J; Chie WC; Fisher S; Guntinas-Lichius O; Hammerlid E; Irarrázaval ME; Jensen Hjermstad M; Jensen K; Kiyota N; Licitra L; Nicolatou-Galitis O; Pinto M; Santos M; Schmalz C; Sherman AC; Tomaszewska IM; Verdonck de Leeuw I; Yarom N; Zotti P; Hofmeister D;
Head Neck; 2015 Sep; 37(9):1358-67. PubMed ID: 24832623
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
Ringash J; Waldron JN; Siu LL; Martino R; Winquist E; Wright JR; Nabid A; Hay JH; Hammond A; Sultanem K; Hotte S; Leong C; El-Gayed AA; Naz F; Ramchandar K; Owen TE; Montenegro A; O'Sullivan B; Chen BE; Parulekar WR
Eur J Cancer; 2017 Feb; 72():192-199. PubMed ID: 28040660
[TBL] [Abstract][Full Text] [Related]
10. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30.
Hammerlid E; Bjordal K; Ahlner-Elmqvist M; Jannert M; Kaasa S; Sullivan M; Westin T
Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):666-73. PubMed ID: 9215381
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.
Xiao C; Zhang Q; Nguyen-Tân PF; List M; Weber RS; Ang KK; Rosenthal D; Filion EJ; Kim H; Silverman C; Raben A; Galloway T; Fortin A; Gore E; Winquist E; Jones CU; Robinson W; Raben D; Le QT; Bruner D
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):667-677. PubMed ID: 27727063
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer.
Kataoka T; Kiyota N; Shimada T; Funakoshi Y; Chayahara N; Toyoda M; Fujiwara Y; Nibu K; Komori T; Sasaki R; Mukohara T; Minami H
Auris Nasus Larynx; 2016 Dec; 43(6):677-84. PubMed ID: 26992271
[TBL] [Abstract][Full Text] [Related]
14. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
15. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
17. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
Truong MT; Zhang Q; Rosenthal DI; List M; Axelrod R; Sherman E; Weber R; Nguyen-Tân PF; El-Naggar A; Konski A; Galvin J; Schwartz D; Trotti A; Silverman C; Singh A; Godette K; Bonner JA; Jones CU; Garden AS; Shenouda G; Matthiesen C; Le QT; Bruner D
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):687-699. PubMed ID: 27727066
[TBL] [Abstract][Full Text] [Related]
18. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy.
Oliveira KG; von Zeidler SV; Podestá JR; Sena A; Souza ED; Lenzi J; Bissoli NS; Gouvea SA
BMC Cancer; 2014 Jan; 14():39. PubMed ID: 24460780
[TBL] [Abstract][Full Text] [Related]
19. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
Osthus AA; Aarstad AK; Olofsson J; Aarstad HJ
Oral Oncol; 2011 Oct; 47(10):974-9. PubMed ID: 21856209
[TBL] [Abstract][Full Text] [Related]
20. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
Pottel L; Lycke M; Boterberg T; Pottel H; Goethals L; Duprez F; Van Den Noortgate N; De Neve W; Rottey S; Geldhof K; Buyse V; Kargar-Samani K; Ghekiere V; Debruyne PR
Eur J Cancer Care (Engl); 2014 May; 23(3):401-12. PubMed ID: 24467393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
